Reduced fetal growth in methadone-maintained pregnancies is not fully explained by smoking or socio-economic deprivation

Addiction

Volumn 109, Issue 3, 2014, Pages 482-488

  Mactier, Helen ^a   Shipton, Deborah ^b   Dryden, Carol ^c   Tappin, David M ^d  

^a UK   (United Kingdom)

^b Glasgow Centre for Population Health   (United Kingdom)

^c WISHAW GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Fetal growth; Head growth; Methadone; Neonatal; Pregnancy; Substance misuse

Indexed keywords

METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; ANATOMY AND HISTOLOGY; BIRTH WEIGHT; COHORT ANALYSIS; FEMALE; FETAL GROWTH RETARDATION; HEAD; HUMAN; MALE; MATERNAL AGE; NEWBORN; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; ORGAN SIZE; POVERTY; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDY; SMOKING; SOCIAL CLASS; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM;

ADULT; ANALGESICS, OPIOID; BIRTH WEIGHT; COHORT STUDIES; FEMALE; FETAL GROWTH RETARDATION; HEAD; HUMANS; INFANT, NEWBORN; MALE; MATERNAL AGE; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; ORGAN SIZE; POVERTY; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; SCOTLAND; SMOKING; SOCIAL CLASS;

EID: 84893818379     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12400     Document Type: Article

References (26)

1. Dryden C., Young D., Hepburn M., Mactier H. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for health care resources. Br J Obstet Gynaecol 2009; 116: 665-671.
2. Rosen T. S., Johnson H. L. Children of methadone-maintained mothers: follow-up to 18 months of age. J Pediatr 1982; 101: 192-196.
3. Hunt R. W., Tzioumi D., Collins E., Jeffery H. E. Adverse neurodevelopmental outcomes of infants exposed to opiate in utero. Early Hum Dev 2008; 84: 29-35.
4. Hulse G. K., Milne E., English D. R., Hollman C. D. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 1997; 92: 1571-1579.
5. Brown H. L., Britton K. A., Mahaffey D., Brizendine E., Hiett A. K., Turnquest M. A. Methadone maintenance in pregnancy: a reappraisal. Am J Obstet Gynecol 1998; 179: 459-463.
6. Liu A. J. W., Sithamparanathan S., Jones M. P., Cook C.-M., Nanan R. Growth restriction in pregnancies of opioid-dependent mothers. Arch Dis Child 2010; 95: F258-262.
7. Burns L., Mattick R. P., Lim K., Wallace C. Methadone in pregnancy: treatment retention and neonatal outcomes. Addiction 2007; 102: 264-270.
8. Minozzi S., Amato L., Vecchi S., Davoli M. Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database Syst Rev 2008; 2: CD006318. doi: 10.1002/14651858.CD006318.pub2
9. Robertson J. R., Daniels A. M. Methadone replacement therapy: tried, tested, effective? J R Coll Physicians Edinb 2012; 42: 133-138.
10. Collins J. W. Jr, Wambach J., David R. J., Rankin K. M. Women's lifelong exposure to neighbourhood poverty and low birth weight: a population-based study. Matern Child Health J 2009; 13: 326-333.
11. Winklbaur B., Jung E., Fischer G. Opioid dependence and pregnancy. Curr Opin Psychiatry 2008; 21: 255-259.
12. The Scottish Government. Scottish Index of Multiple Deprivation 2004. Edinburgh 2004. Available at: http://www.scotland.gov.uk/Publications/2004/06/19421/38085 (accessed 20 November 2013).
13. Kramer M. S. Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ 1987; 65: 663-737.
14. Ehrenberg H. M., Dieker L., Milluzzi C., Mercer B. M. Low maternal weight, failure to thrive in pregnancy, and adverse pregnancy outcomes. Am J Obstet Gynecol 2003; 189: 1726-1730.
15. Mengel M. B., Searight H. R., Cook K. Preventing alcohol-exposed pregnancies. J Am Board Fam Med 2006; 19: 494-505.
16. McGlone L., Mactier H., Cooper G., Hassan H. Alcohol and drug exposure in infants born to mothers prescribed methadone during pregnancy. Arch Dis Child 2013; 98: F542-544.
17. Johnston K., Gerada C., Greenough A. Substance misuse during pregnancy. Br J Psychiatry 2003; 183: 87-89.
18. Chauhan S. P., Magann E. F., Zhao Y., Klimpel J. M., Brown J. A., Morrison J. C. Maternal body mass index: a poor diagnostic test for detection of abnormal fetal growths. Am J Perinatol 2011; 28: 773-780.
19. Jaddoe V. W. V., Verburg B. O., de Ridder M. A. J., Hofman A., Mackenbach J. P., Moli H. A. etal. Maternal smoking and fetal growth characteristics in different periods of pregnancy. Am J Epidemiol 2007; 65: 1207-1215.
20. Fardi W. O., Dunlop S. A., Tait R. J., Hulse G. K. The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. Curr Neuropharmacol 2008; 6: 125-150.
21. Hamilton R., McGlone L., MacKinnon J. R., Russell H. C., Bradnam M. S., Mactier H. Ophthalmic, clinical and visual electrophysiological findings in children born to mothers prescribed substitute methadone in pregnancy. Br J Ophthalmol 2010; 94: 696-700.
22. Whalsten V. S., Sarman I. Neurobehavioural development of preschool-age children born to addicted mothers given opiate maintenance treatment with buprenorphine during pregnancy. Acta Paediatr 2013; 102: 544-549.
23. Jones H. E., Kaltenbach K., Heil S. H., Stine S. M., Coyle M. G., Arria A. M. etal. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med 2010; 363: 2320-2331.
24. Lacroix I., Berrebi A., Garipuy D., Schmitt L., Hammou Y., Chaumerliac C. etal. Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study. Eur J Clin Pharmacol 2011; 67: 1053-1059.
25. Pinot H., Maskrey V., Swift L., Rumball D., Wagle A., Holland R. The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment. J Subst Abuse Treat 2010; 39: 340-352.
26. Whitham J. N., Spurrier N. J., Sawyer M. G., Baghurst P. A., Taplin J. E., White J. M. etal. The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials. Neurotoxicol Teratol 2010; 32: 280-288.